Total and allergen-specific IgE levels during and after pregnancy in relation to maternal allergy.
Type 2 T-helper cell (Th2)-skewed immunity is associated with successful pregnancy and the ability to easily direct immune responses to a Th2-polarised profile may be an evolutionary benefit. The Th2-like immunity associated with allergic disease might generate favourable effects for the maintenance of pregnancy, but could also promote development of Th2-like immune responses and allergic disease in the offspring. The aim of this study was to explore, by using IgE as a stable proxy for Th2, the Th1/Th2 balance in allergic and non-allergic women by measuring allergen-specific and total IgE antibody levels in plasma during pregnancy and after delivery. Specific and total IgE antibody levels were determined by ImmunoCAP technology at five occasions during pregnancy (gestational weeks 10-12, 15-16, 25, 35 and 39), as well as at 2 and 12 months after delivery. Thirty-six women without and 20 women with allergic symptoms were included, of whom 13 were sensitised with allergic symptoms and 30 were non-sensitised without allergic symptoms. The levels of total IgE, but not allergen-specific IgE, were increased during early pregnancy when compared to 12 months after delivery in the sensitised women with allergic symptoms, but not in the non-sensitised women without allergic symptoms (p<0.01). This increase in total IgE levels during early pregnancy only in the sensitised women with allergic symptoms indicates that allergy is associated with an enhanced Th2 deviation during pregnancy.
Sandberg
Martina
M
Division of Pediatrics, Department of Clinical and Experimental Medicine, and Clinical Research Centre, Linköping University, Linköping SE-581 85, Sweden. martina.sandberg@liu.se
Frykman
Anne
A
Jonsson
Yvonne
Y
Persson
Marie
M
Ernerudh
Jan
J
Berg
Göran
G
Matthiesen
Leif
L
Ekerfelt
Christina
C
Jenmalm
Maria C
MC
D000485:Allergens / Q000276:immunology*; D001724:Birth Weight; D000939:Epitopes; D005260:Female; D005865:Gestational Age; D006801:Humans; D006967:Hypersensitivity / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007073:Immunoglobulin E / Q000097:blood*; D007231:Infant, Newborn; D049590:Postpartum Period; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D018418:Th2 Cells / Q000276:immunology
D000485:Allergens; D000939:Epitopes; D007073:Immunoglobulin E